Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D M Burns

Showing results (81-90 of 82) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 82 results.
Circulation|July 1, 1997
First chronic platelet glycoprotein IIb/IIIa integrin blockade. A randomized, placebo-controlled pilot study of xemilofiban in unstable angina with percutaneous coronary interventionsC Simpfendorfer, K Kottke-Marchant, M Lowrie, et al.
Scientific Reports|July 23, 2021
High-throughput human primary cell-based airway model for evaluating influenza, coronavirus, or other respiratory viruses in vitroA L Gard, R J Luu, C R Miller, et al.
Pageof 9

Showing results (81-90 of 82) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 82 results.
Circulation|July 1, 1997
First chronic platelet glycoprotein IIb/IIIa integrin blockade. A randomized, placebo-controlled pilot study of xemilofiban in unstable angina with percutaneous coronary interventionsC Simpfendorfer, K Kottke-Marchant, M Lowrie, et al.
Scientific Reports|July 23, 2021
High-throughput human primary cell-based airway model for evaluating influenza, coronavirus, or other respiratory viruses in vitroA L Gard, R J Luu, C R Miller, et al.
Pageof 9